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Acute viral infections often induce a transient period of immune deficiency in which the host’s T cells fail to
proliferate in response to T-cell mitogens and fail to make an antigen-specific memory recall response. This has
been associated with the enhanced sensitivity of these highly activated T cells to undergo apoptosis, or acti-
vation-induced cell death (AICD), upon T-cell receptor ligation. Here we show that gamma interferon receptor-
deficient (IFN-g R2/2) mice mount a T-cell response to lymphocytic choriomeningitis virus (LCMV) infection
but fail to undergo the transient immune deficiency. Instead, their T cells were hyperproliferative and rela-
tively, but not completely, resistant to AICD. The immune response returned to homeostasis, but with delayed
kinetics, in parallel with delayed clearance of the virus. Wild-type mice receiving high doses of disseminating
LCMV Clone 13 are known to undergo clonal exhaustion of their virus-specific cytotoxic T lymphocytes (CTL).
To determine whether this process was mediated by AICD associated with IFN-g or with Fas-Fas ligand
interactions, LCMV-specific precursor CTL frequencies were examined in LCMV Clone 13-infected IFN-g
R2/2 or lpr (Fas-deficient) mice. In both instances, viral persistence was established and CTL precursors were
greatly eliminated. This finding indicates that clonal exhaustion of CTL does not require IFN-g or Fas, even
though both molecules influence AICD and the transient immune deficiency seen in the LCMV infection.
Apoptotic regulation of T-cell responses has been implicat-
ed in the transient immune deficiencies associated with many
viral infections (33, 36), in the silencing of the immune
response and its return to homeostasis at the end of infection
(32), and in the selective clonal exhaustion of antigen-specific T
cells that occurs under conditions of high antigen load during
disseminating infections (23). Among the molecules implicated in
the regulation of T-cell apoptosis are cell surface receptors such
as Fas-Fas ligand (FasL) (4, 6, 15, 37, 38) and tumor necrosis
factor-tumor necrosis factor receptor (49), intracellular proteins
such as Bcl-2 and its many relatives (35), and caspases, a family of
cysteine proteases including interleukin-1 convertase enzyme
(ICE) family proteases (21, 27). A number of cytokines have also
been proposed as factors inducing apoptosis or conditioning cells
to become susceptible to apoptosis (8, 17). One of these, gamma
interferon (IFN-g), is well known for its capacity for immune
modulation. IFN-g can influence the generation of cell-mediated
immune responses both by suppressing the growth of Th2 cells
and by promoting the differentiation of Th1 cells from either
naive or memory CD41 cells (3, 9). Some evidence implicating
IFN-g as a contributor to T-cell death has been presented. The
induction of apoptosis of Th1 cell lines is associated with IFN-g
gene expression and secretion following CD3/T-cell receptor
(TCR) mobilization in the absence of accessory cells, and apo-
ptosis can be prevented by the addition of anti-IFN-g antibodies
(11, 18). Recent studies have shown that splenocytes from mice
with the inability to respond to IFN-g exhibit increased levels of
proliferation in response to mitogen and alloantigen (5, 48). Im-
mune modulation by IFN-g via its antiproliferative and proapop-
totic actions has been proposed as an additional mechanism that
contributes to clonal deletion and the maintenance of self toler-
ance after antigenic challenge (18), yet its role in the apoptotic
processes of T cells induced during viral infection is unknown.
To examine the role of IFN-g in T-cell apoptosis associated
with immune deficiency, immune silencing, and clonal exhaus-
tion in virus infections, we have selected to study the lympho-
cytic choriomeningitis virus (LCMV) model of infection in
mice. Infection of mice with low doses of LCMV strain Arm-
strong (LCMV-Arm) results in a massive expansion in the
number and activity of CD81 T cells, which are responsible for
the clearance of the virus. These mice, like many other virus-
infected hosts, develop a period of transient immune deficiency
at which time the proliferative responses to common mitogens
and recall antigens are depressed (14, 33). This immune defi-
ciency is a consequence of the enhanced susceptibility of the
activated T cells to undergo apoptosis upon strong TCR stim-
ulation (33), a phenomenon known as activation-induced cell
death (AICD) (39). During this period of immune deficiency,
the splenic T-cell number substantially declines in a process we
term immune silencing. Immune silencing, which occurs after
detectable viral antigen is cleared, is associated with high levels
of apoptosis within the T- and B-cell populations of the spleen
(32). After the immune silencing process, the mice are left with
high levels of virus-specific precursors in their T-cell memory
pool. Infection of mice with high doses of a variant of LCMV
(Clone 13) that replicates to higher titers and rapidly dissem-
inates results in a transient antiviral cytotoxic T-lymphocyte
(CTL) response followed by a clonal exhaustion of the virus-
specific CTL response and the development of a persistent
infection without CTL memory (23). Because the injection of
high levels of T-cell-specific peptides can induce apoptosis and
eliminate T-cell responses in vivo (43), a likely mechanism for
clonal exhaustion under conditions of this disseminating
LCMV infection is AICD (apoptosis) of this antigen activated
T-cell population. Thus, regulation of T-cell apoptosis during
viral infections can be examined by using LCMV-infected mice
for analyses of the susceptibility of activated lymphocytes to
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undergo apoptosis during the period of immune deficiency, of
downregulation of CD81 cell number, and of clonal exhaus-
tion. If IFN-g governs efficient downregulation of the CD81
T-cell response, then one possible outcome of infection of
IFN-g receptor (IFN-g R)-deficient (IFN-g R2/2) mice with
LCMV-Arm would be failure to reestablish homeostatic num-
bers of CD81 T cells and, following infection with LCMV
Clone 13, a failure to undergo clonal exhaustion. We report
here that mice with a defect in the ability to respond to IFN-g
have T cells that are impaired in the ability to undergo apo-
ptosis in vitro and have no evidence of transient immune de-
ficiency during acute viral infection. These mice are delayed in
the process of immune silencing of CD8 T-cell number and
activity and clear the infection with delayed kinetics, but the
cell numbers ultimately decline, and expected frequencies of
CTL precursors (CTLp) are established. The virus-specific T
cells from IFN-g R2/2 mice as well as Fas-deficient lpr mice
also underwent clonal exhaustion following infection with
LCMV Clone 13. These results indicate that IFN-g is impor-
tant for the induction of transient immune deficiency but is not
required for the immune silencing or clonal exhaustion.
MATERIALS AND METHODS
Mice. 129 SV/EV wild-type control mice and 129 mice homozygous for a
targeted mutation disrupting the b subunit of the murine IFN-g R were originally
derived and provided by M. Aguet (13). Mice were housed in a specific pathogen-
free environment and were used at 6 to 12 weeks of age. C57BL/6J and B6.MRL-
Faslpr (CD95-deficient) mice were purchased from Jackson Laboratory (Bar
Harbor, Maine) and placed in conventional housing. Mice were infected either
intraperitoneally with 5 3 104 PFU of LCMV-Arm or intravenously with 4 3 107
PFU of LCMV Clone 13 (fourth-passage LCMV Clone 13-Armstrong was ob-
tained from M. B. A. Oldstone, Scripps Clinic and Research Foundation, La
Jolla, Calif.).
Proliferation assays. Spleens were ground between the frosted ends of micro-
scope slides, and the erythrocytes were lysed in 0.84% ammonium chloride. The
cells were washed with RPMI 1640 culture medium supplemented with 2 mM
L-glutamine, 100 mg of penicillin-streptomycin per ml, 5 3 1025 M 2-mercapto-
ethanol (all from Sigma Chemical Co., St. Louis, Mo.), 0.1 mM sodium pyruvate
(Gibco, Grand Island, N.Y.), 0.1 mM nonessential amino acids (Gibco), 10 mM
HEPES, and 10% fetal calf serum (Sigma). Splenic T cells were enriched by
nylon wool purification as previously described (33) and used for the determi-
nation of susceptibility to apoptosis. Enriched splenic T cells from infected and
uninfected mice were cultured for 36 to 48 h in various culture conditions as
previously described (19), with the exception that tissue culture plates were
coated overnight with 2 to 5 mg of purified mouse anti-CD3 (clone 145-2C11;
Pharmingen). Human recombinant interleukin-2 (IL-2) was from Cetus (Em-
eryville, Calif.). Half of the culture was used to determine proliferative responses
by measuring the incorporation of [3H]thymidine (1 mCi/well; Amersham, Ar-
lington Heights, Ill.) during the final 6 h of incubation.
TUNEL staining. The remaining half of the culture containing approximately
5 3 105 cells was used to determine the percentage of apoptotic cells by the
terminal nucleotidyltransferase (TdT)-mediated dUTP-biotin nick end labeling
(TUNEL) assay modified for flow cytometry (47). Briefly, the cultured cells were
surface labeled with fluorescein isothiocyanate-conjugated anti-mouse CD8a
(clone 53-6.7) and phycoerythrin-conjugated anti-mouse CD4 (H129.19) (Phar-
mingen, San Diego, Calif.) and then fixed with paraformaldehyde. The cells were
then permeabilized with 70% cold ethanol, washed, and resuspended in terminal
transferase reaction buffer that contained 0.2 M potassium cacodylate, 25 mM
Tris-HCl, 0.25 mg of bovine serum albumin per ml, 2.5 mM cobalt chloride, 10
U of TdT, and 0.5 nmol of biotin-16-dUTP (B-dUTP) (all from Boehringer
Mannheim, Indianapolis, Ind.) in a total volume of 50 ml. The incorporated
B-dUTP was detected by the addition of streptavidin conjugated with Tricolor
(Caltag, Burlingame, Calif.). The samples were resuspended in phosphate-buff-
ered saline–2% fetal calf serum for flow cytometric analysis.
Lymphocyte phenotyping. The percentages of splenic CD31 and CD81 T
lymphocytes were identified by double surface immunofluorescence staining with
anti-mouse CD3 conjugated with phycoerythrin (Gibco) and anti-mouse CD8
conjugated with fluorescein isothiocyanate (Gibco). A total of 106 cells were
stained, fixed with 1% paraformaldehyde, and analyzed on either a FACStar Plus
or a FACS 440 (both from Becton Dickinson, San Jose, Calif.).
Cytotoxicity assays. Cell-mediated cytotoxicity was determined by a standard
CTL assay (34). Various numbers of effector splenocytes were plated in triplicate
to achieve the desired effector-to-target cell ratio. LCMV-infected or uninfected
MC57G fibroblasts were used as target cells. Target cells were labeled with 100
mCi of 51Cr (Amersham) and mixed with the effector cells for a 5- to 6-h incu-
bation. Supernatant from each well was harvested and counted. Percent specific
lysis was calculated from the formula 100 3 [(experimental cpm 2 spontaneous
cpm)/(maximum cpm 2 spontaneous cpm)]. One lytic unit (LU) was defined as
the number of lymphocytes necessary to obtain 30% specific lysis of 104 target
cells. Total LU was calculated from the total number of lymphocytes per spleen.
Limiting dilution assay for virus-specific CTLp. The assay used the procedure
of Moskophidis et al. (24), modified as noted elsewhere (26, 40). Briefly, dilu-
tions of splenocytes from infected mice were stimulated with irradiated LCMV-
infected syngeneic peritoneal exudate cells and with syngeneic splenocytes as a
source of feeder cells. The cultures were maintained in AIM-V medium (Gibco)
supplemented with a 16% culture supernatant from a gibbon lymphoma tumor
cell line, MLA.144 (American Type Culture Collection, Rockville, Md.), as a
source of IL-2 (31). The cultures were restimulated on day 4 with irradiated
virus-infected PECs. The level of cytolytic activity was measured on day 8, at
which time the individual wells were split two ways and incubated 8 h with a
51Cr-labeled target cell line KO (a murine H-2b cell line from simian virus
40-transformed kidney cells from S. Tevethia, Pennsylvania State University,
Hershey), either infected with LCMV or uninfected. Positive wells were identi-
fied as wells that exceeded the mean chromium release from wells without
effector cells by 3 standard deviations. Wells containing cells that lysed unin-
fected syngeneic targets were eliminated from the calculations. The precursor
frequency was determined by chi-square analysis based on maximum likelihood
(45) by a computer program provided by R. Miller (University of Michigan, Ann
Arbor).
Virus titer assay. Blood or spleen homogenates from infected mice were
titrated for virus by plaque formation on Vero (American Type Culture Collec-
tion) cell monolayers.
RESULTS
CD81 T-cell silencing and LCMV clearance are delayed in
IFN-g R2/2 mice. Mice infected with LCMV have a major ex-
pansion of antiviral CD81 T cells that are responsible for
clearing the infection. Changes in total splenic T-cell number
and in CD81 cell number, and the virus-specific CTL re-
sponses from IFN-g R2/2 mice and the 129 SV/EV controls,
are shown in Table 1. In the 129 SV/EV mice, both splenic
T-cell numbers and CD81 cell numbers doubled over the first
10 days of infection, with the exception of experiment 4, in
which the CD81 cell number doubled but the overall T-cell
expansion was modest. In these mice, peak viral titers were
detected 4 days postinoculation (p.i.), and no virus-positive
mice were detected after day 8 of infection (Table 2) (25). In
contrast to the efficient clearance of the virus in the 129 SV/EV
mice, there was prolonged viral replication in the IFN-g R2/2
mice (Table 2). Clearance of virus from the spleens of the
IFN-g R2/2 mice occurred between 10 and 15 days p.i., and
significantly higher titers of virus were found 8 days p.i. (P 5
0.0003) in IFN-g R2/2 mice compared to the wild-type con-
trols. The trend of increased viral titers in IFN-g R2/2 mice
was also present at 5 (P 5 0.03) and 6 (P 5 0.04) days p.i.
Associated with the delayed clearance of virus was a three- to
fivefold expansion in the number of splenic CD8 cells that was
increased 13 to 15 days p.i. (Table 1).
Primary CTL activity was measured against syngeneic LCMV-
infected target cells. As expected, the LCMV-specific cytotoxic
activity peaked in the control mice 10 to 11 days p.i. and then
rapidly declined (Table 1). Some of the IFN-g R2/2 mice also
had peak levels of activity days 10 to 11 p.i., but a notable
finding was the levels of lytic activity present on days 13 to
15 p.i. This activity was even more pronounced when the over-
all cellularity of the spleen was considered (total LU). In each
experiment, there was an increase in the total LU present in
the spleens from the IFN-g R2/2 mice compared to the wild-
type controls 13 to 15 days p.i. Even though the total LU was
high 13 to 15 days p.i. in the IFN-g R2/2 mice, the level
dropped dramatically 17 days p.i. (total LU 5 30) and returned
to normal (total LU , 1) 20 days p.i. These results indicate
that the LCMV-infected IFN-g R2/2 mice have elevated levels
of virus replication, a delayed rate of virus clearance, and a
much delayed rate of immune silencing (both in cell number
and in activity) compared to the 129 SV/EV mice.
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Splenic T cells from IFN-g R2/2 mice infected with LCMV
are hyperproliferative and fail to develop transient immune
deficiency. Immune deficiency and the susceptibility to AICD
of T cells from LCMV-Arm-infected mice was determined by
the combined methods of measurement of lymphocyte prolif-
eration in response to stimulation by immobilized anti-CD3
and detection of apoptotic cells in these cultures by flow cy-
tometry. As shown in Fig. 1C, contrasting with the transient
100-fold reduction in [3H]thymidine uptake observed in the
129 SV/EV littermates on days 7 to 8 p.i., mice with an inability
to respond to IFN-g had a slight (1.7-fold) reduction in the
proliferative response compared to the response on day 0 (P 5
0.03). Even at a comparable time point where there was min-
imal virus replication in the IFN-g R2/2 mice, and when the
T-cell population was expanding and expressing activation
markers (days 10 to 14), there was no major impairment in the
ability of splenocytes to proliferate to anti-CD3: the average
inhibition of the proliferative response 10 to 14 days p.i. was
from 2.1- to 2.8-fold less than the proliferative response on day
0. In addition, the proliferative response of T cells to IL-2 in
the absence of receptor stimulation was significantly elevated
in IFN-g R2/2 mice on days 7 to 10 p.i.: Fig. 1B shows that
it was nearly 10-fold higher than in control infected mice
(P values range from ,0.01 to ,0.05). As IFN-g can mediate
both antiproliferative and proapoptotic effects, the T-cell pro-
liferative results from IFN-g R2/2 mice could have reflected
either increased proliferation or decreased levels of apoptosis
in the cultures.
Splenic CD81 T cells from LCMV-infected IFN-g R2/2 mice
are resistant to AICD during the period of immune silencing.
To address the question of whether the cells from the IFN-g
R2/2 mice were impaired in the ability to undergo apoptosis,
we used the TUNEL flow assay to specifically measure the
level of apoptotic CD81 cells in the anti-CD3-stimulated cul-
tures. Representative histograms from individual experiments
have been compiled to show the overall trend of susceptibility
of CD81 cells to apoptosis at different time points during
LCMV infection. T cells from uninfected (day 0) 129 SV/EV
mice or IFN-g R2/2 mice proliferated after incubation with
anti-CD3 (Fig. 1C), and the CD81 cell population was 4 to
11% apoptotic (Fig. 2). Nine days after LCMV infection of the
129 SV/EV mice, the numbers of apoptotic cells in culture rose
to 25% following anti-CD3 stimulation. This susceptibility to
anti-CD3-mediated cell death was greatest on day 10 of infec-
tion, when 60% of the CD8 cells were apoptotic after 48 h in
culture. Day 10 corresponded to the peak of splenic CD81 cell
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TABLE 2. Splenic LCMV titers in 129 SV/EV
and IFN-g R2/2 micea
Days p.i.
Titer (log10 PFU/spleen 6 SD)b
129 SV/EV IFN-g R2/2
3 3.7 6 1.3 (5c) 5.1 6 0.2 (2)
4 5.2 6 1.1 (6) 4.9 6 0.6 (3)
5 4.1 6 1.2 (6) 5.4 6 0.2 (3)
6 2.7 6 0.7 (6) 3.4 6 0.2 (4)
8 ,2.4 (8) 3.4 6 0.4d (6)
10 ,2.0 (4) ,2.4 (4)
13 ,2.0 (7) ,1.0 (7)
a Age-matched IFN-g R2/2 mice and wild-type control (129 SV/EV) mice
were infected i.p. with 5 3 104 PFU of LCMV.
b Spleen homogenates were titrated on Vero cells for 4 days in an agarose
overlay assay. Plaques were detected on day 5 by a neutral red overlay.
c Number of mice per time point. Individual spleens were titrated.
d Statistically significant increase (P , 0.05).
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expansion in the 129 SV/EV mice (Table 1). By 13 days p.i., the
proportion of the CD8 cells that were driven into death fell to
30% as the splenic CD8 number declined. In contrast to the
129 SV/EV mice, the appearance of CD81 cells susceptible to
apoptosis was delayed in the IFN-g R2/2 mice, consistent with
the delay in CD81 cell expansion and viral clearance (Tables 1
and 2). Nine to 10 days p.i., at the cusp of CD81 cell expansion
and the start of viral clearance, CD81 cells from the IFN-g
R2/2 mice remained resistant to anti-CD3-mediated death
(Fig. 2B). At this time point, only 15 to 16% of the CD8 cells
were apoptotic. The majority of the IFN-g R2/2 mice cleared
LCMV by 13 days p.i., by which time there was a three- to
fivefold expansion in the number of CD8 cells, similar to the
conditions observed on day 10 in the 129 SV/EV mice, at which
point the CD8 cells from 129 SV/EV mice showed maximum
susceptibility to anti-CD3-mediated cell death. On day 13, the
CD81 cells from IFN-g R2/2 mice were more susceptible to
anti-CD3-mediated cell death (25% of the cells were apoptotic
after culture), but there were many more viable cells present
than at the day 10 time point in wild-type mice, when one con-
siders the 100-fold difference in proliferation (Fig. 1C). Thus,
CD81 cells from LCMV-infected IFN-g R2/2 mice are rela-
tively resistant to apoptosis in addition to being hyperprolif-
erative. This finding suggests that IFN-g is a factor required for
efficient induction of AICD and that it is important for the
transient immune deficiency during virus infections.
T cells from IFN-g R2/2 mice and Fas-deficient mice under-
go clonal exhaustion in persistent viral infection. Infection of
mice with a high dose of a disseminating strain of virus, LCMV
Clone 13, results in elimination of virus specific CTL and leaves
the host in a the state of viral persistence (23). In that immu-
nological setting, both high levels of circulating antigen and
virus-specific activated T cells would be present in the same en-
vironment, the conditions necessary for induction of AICD. To
test the hypothesis that clonal exhaustion may occur by AICD,
we infected wild-type, Fas-deficient (lpr), or IFN-g R2/2 mice
with LCMV Clone 13 and measured CTLp frequencies 6 weeks
p.i. When infected with low doses of LCMV-Arm, all of the
mice were capable of developing normal memory CTL re-
sponses. From 200 to over 4,700 CTLp per 50,000 CD81 cells
were detected in both wild-type and mutant mice 6 weeks p.i.
with LCMV-Arm (Table 3). The values for the LCMV-Arm-
infected 129 SV/EV and IFN-g R2/2 mice used in these ex-
periments were comparable to CTLp frequencies reported
elsewhere by our group (129 SV/EV, 1,785 and 3,333 CTLp/
50,000 CD81 cells; IFN-g R2/2, 1,282 and 4,545 CTLp/50,000
CD81 cells). These values were within the normal range for
mice immune to LCMV-Arm (41, 42). However, when infected
with LCMV Clone 13, all mice became persistently infected
after intravenous inoculation. The titer of LCMV Clone 13
from the blood of infected C57BL/6 mice was 3.7 6 0.7 log
PFU/ml (n 5 11), the titer for lpr mice was 5.2 6 0.3 PFU/ml
(n 5 7), the titer for 129 SV/EV mice was 2.3 6 0.3 PFU/ml
(n 5 3), and the titer for IFN-g R2/2 mice was 3.5 6 0.1
PFU/ml (n 5 4). Persistent infection resulted in a pronounced
2- to 3-log10 reduction in the number of CTLp present 6 weeks
after infection of both lpr and IFN-g R2/2 mice and their
wild-type controls. Thus, mice with selective deficiencies in the
ability to undergo AICD are clearly capable of undergoing
clonal exhaustion of virus-specific CTL in the presence of cir-
culating viral antigen.
DISCUSSION
Highly activated cycling T cells are prone to undergo apo-
ptosis if stimulated strongly through the TCR in a process
termed AICD (39). In vivo, AICD has been demonstrated in a
murine CD41 transgenic T-cell system to require Fas-FasL
interactions (43), and IFN-g has been shown to upregulate Fas
expression on T cells (28–30). AICD is a mechanism for the
transient immune deficiency observed during the height of an
acute viral infection, at which time T cells fail to proliferate in
the presence of mitogen or recall antigens (12, 22, 32, 33). The
model of LCMV infection allows investigation of the mecha-
nism(s) for induction of apoptosis in the settings of transient
immune deficiency, immune silencing, and clonal exhaustion.
We report here that mice with a defect in the ability to respond
to IFN-g had no evidence of transient immune deficiency dur-
ing acute LCMV infection, as measured by proliferative re-
sponses, but were delayed in the process of viral clearance and
immune downregulation. T cells from these mice exhibited
impaired ability to undergo apoptosis in vitro, but immune
silencing eventually occurred at low doses of virus, and clonal
exhaustion occurred at high doses. Together with our previous
studies with lpr mice (19, 32), this finding indicates that neither
FIG. 1. Proliferative responses of splenic T cells from wild-type 129 SV/EV
(1/1) and IFN-g R2/2 (2/2) mice after 36 to 48 h of culture in medium alone
(A) or supplemented with IL-2 (B) or anti-CD3 (C). The mean counts per
minute of [3H]thymidine incorporation are 6 1 standard deviation plotted. The
results are averaged from the values for individual mice, with a minimum of two
mice tested per time point. The Student t test was used to generate P values for
data from days 7 to 13 p.i.
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Fas nor IFN-g is necessary for immune silencing or clonal
exhaustion of CD81 T cells, although these molecules affect
the susceptibility of T cells to AICD.
AICD has also been postulated to play a role in immune
silencing and return to homeostasis (10, 20, 44, 46). In the
setting of low-dose LCMV-Arm infection, this seems unlikely,
as viral antigen is cleared prior to the onset of immune silenc-
ing (16), and mice with deficiencies in molecules known to
regulate AICD, such as Fas and FasL, undergo normal im-
mune silencing (19, 32). There is also evidence that CD81 T
cells do not require a second encounter with antigen to un-
dergo apoptosis (2). AICD is thought to depend on reexposure
of activated T cells to TCR ligation, but Alexander-Miller et al.
suggest that the commitment to apoptosis has already occurred
during the initial antigenic encounter, indicating that in their
system cycling CTL do not require a second encounter with
antigen to induce apoptosis (2). This finding suggests that
AICD may not be the major mechanism for establishment of
CD81 T-cell homeostasis after resolution of viral infection.
The levels of antigen present at the end of the immune
response have been proposed to affect the outcome of TCR
ligation of activated cells: AICD is the result when large quan-
tities of antigen are present (1). However, when concentrations
of antigen are low, as in the setting of LCMV-Arm infection,
activated T cells may be prone to death resulting from depri-
vation of growth factors such as IL-2 and stromal cell factor(s)
which are postulated to promote survival of T cells by main-
taining high levels of Bcl-xL and intracellular glutathione, an
antioxidant (1), in a process independent of Fas ligation. We
have previously shown that mice with enforced expression of
Bcl-2, which can protect lymphocytes from cytokine withdraw-
al-induced apoptosis, clear LCMV normally, have a normal
reduction in T-cell number, and exhibit increased numbers of
FIG. 2. Detection of DNA fragmentation associated with CD81 apoptotic cells following stimulation for 36 to 48 h in the presence of anti-CD3. Apoptotic CD81
cells were detected by the TUNEL assay followed by the addition of streptavidin-Tricolor. The percent apoptotic cells was determined from the cell numbers present
in the M1 region. The profiles are from individual mice and are representative of at least two mice tested per time point.
TABLE 3. LCMV-specific CD81 CTLp frequencies in mice
infected with either LCMC-Arm or LCMV Clone 13
Mouse
strain Expt
LCMV-Arm LCMV Clone 13
CTLp/50,000
CD81 cells
95%
confidence
interval
CTLp/50,000
CD81 cells
95%
confidence
interval
C57BL/6 1 262 331–192 ,3
2 1,250 1,724–793 ,3
3 2,173 3,125–1,282 ,2
4 355 467–244 ,2
5 575 735–423 23 34–12
6 982 1,372–590 11 13–9
7 20 29–10
Avg 933 9
B6.MRL-Fas lpr 1 1,613 2,000–1,250 ,2
2 1,190 1,563–820 ,2
3 459 568–320 100 135–66
4 ,2
5 29 40–18
6 20 26–15
7 ,1
8 14 18–10
Avg 1,087 21
129 SV/EV 1 1,667 2,083–1,190 34 45–23
2 204 277–132
Avg 935 34
IFN-g R2/2 1 .1,163 ,1.5
2 .4,762 9 15–3
3 6 11–1
4 10 17–2
Avg .2,962 6.6
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apoptotic cells in the spleens of mice recovering from infection
(32). This finding suggests that cytokine deprivation alone is
not sufficient to drive cells into apoptosis, although the special
effects of Bcl-xL were not investigated (32). Also, the frequen-
cies and specificities of LCMV-specific CTLp are only margin-
ally affected by the decline in T-cell number during immune
silencing (42), arguing against receptor-dependent apoptosis
of those T cells and consistent with stromal cell-mediated res-
cue of activated cells independent of antigen.
Wild-type mice receiving high doses of disseminating LCMV
Clone 13 are known to undergo clonal exhaustion of their
virus-specific CTL. The mechanism driving this elimination of
antigen-specific T cells remains unclear. Clonal exhaustion
may occur during generalized infections with noncytopathic
viruses, when an excess of antigen on localized and peripheral
antigen-presenting cells may induce all the matured effector T
cells to die off within a few days. This repeated exposure to
antigen would drive them into apoptosis, resulting in a deletion
of this specificity from the repertoire (7, 50). Attempts to
prevent clonal exhaustion by infusions of IL-1 or IL-2 were
unsuccessful, indicating that interleukins do not seem to be the
limiting factor in the exhaustion of CTLs (23). We report here
that viral persistence was established and CTLp were greatly
eliminated following LCMV Clone 13 infection of IFN-g R2/2
and lpr (Fas-deficient) mice, suggesting that clonal exhaustion
of CTL also does not require IFN-g or Fas, even though both
molecules influence AICD and the transient immune defi-
ciency seen in the LCMV infection.
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